Biotech Analyst Schimmer holds a conference call with CEO Kumar on December 6 at 11 am hosted by Cantor Fitzgerald.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBIO:
- BridgeBio Pharma (BBIO) Stock Surges on FDA Approval of Lead Treatment
- Biotech Alert: Searches spiking for these stocks today
- Macy’s uncovers employee fraud, Summit to be acquired: Morning Buzz
- BridgeBio price target raised to $48 from $45 at Scotiabank
- BridgeBio FDA approval ‘significant clearing event,’ says Citi
Questions or Comments about the article? Write to editor@tipranks.com